May 16, 2023

Biophore India Pharmaceuticals Receives CDSCO Approval for Cannabidiol Oral Solution

Biophore India Pharmaceuticals, a Hyderabad-based company, has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market Cannabidiol active ingredient in India. This approval is a significant milestone as it represents the first approval of a Cannabidiol-based product in India, offering a unique therapy option for patients. The CDSCO has granted […]

Biophore India Pharmaceuticals Receives CDSCO Approval for Cannabidiol Oral Solution Read More »